Der nächste LP geht an den Start - Hemisphere Pharma

"With this Transaction completed, Newstrike, under the leadership of our incoming CEO, Jay Wilgar, and his highly accomplished executive team, is now well-positioned to build significant value by successfully executing our growth strategy for the developing cannabis market - a market with exponential potential. Our incoming management team bring operational and strategic experience in regulated pharmaceutical manufacturing and consumer products, the cultivation of cannabis at scale and a proven track record in building value in a highly-regulated industry. This team will be complemented by an expanded and responsive shareholder-base and a board and advisory team experienced in guiding public companies and effectively responding to the requirements of the capital markets," noted Scott Kelly, the Executive Chair of Newstrike. Kelly added that, "this new chapter for Newstrike would not have been possible without the dedication and many years of stewardship provided by Mr. John Pollock and the other outgoing Directors: Tom Flynn and Barrie Hancock, who provided the guidance and tenacity that allowed us to first identify and now close this exciting and paradigm changing opportunity for Newstrike and its shareholders."

"Closing this Transaction expands and accelerates our growth strategy in the best possible ways," said Jay Wilgar, incoming CEO of Newstrike and founder of HPI. "We emerge at an extraordinary time: the dawn of a new consumer category and all the related opportunities that it presents. We also emerge with the best possible team, possessing the right expertise, and supported by a very strong shareholder base with a track record of investing in some of the most successful companies in the emerging cannabis sector. I look forward to continuing to realize on the opportunities that are presented and building value for our shareholders in doing so," added Wilgar. homepage hemisphere pharma - Original Pressemitteilung